Super stoked to see this recognition of Bryce’s work developing a new #CART cell therapy for #DMG #DIPG Go #DunLab 💪

Incredibly proud to share the latest work from #DunLab, published in #CancerResearch! We highlight the combination of ONC201 and paxalisib for the treatment of DMG, the preclinical data informing PNOC022. Follow this tweetorial for a summary: (1/10) aacrjournals.org/cancerres/arti…

Very proud moment having my first review article published in Trends in Cancer. Big thank you @DilanaStaudt Matt Dun, PhD and Alicia from #DunLab and Nick Vitanza Michelle Monje🎗️ 🟦 for lending your expertise! #DMG #DIPG #CART

Come join the team!

Greatest cheer on a plane outside of a miracle landing

Diffuse midline glioma #DMG is uniformly fatal & the leading killer of kids Currently it lacks approved treatments other than radiotherapy Dordaviprone #ONC201 shows a prelim benefit for #DIPG patients, by why? Here we summarise it's mechanisms to show why shorturl.at/gBJT1

Great 2C the cover of Trends in Cancer Oct 23 featuring #DunLab #CSRG's paper. CART T cell therapies for diffuse midline glioma: Trends in Cancer cell.com/trends/cancer/… Again, congratulations Bryce Thomas @DilanaStaudt &thanks to our collaborators Nick Vitanza & Michelle Monje🎗️ 🟦

Great day at the Uni Newcastle Research #SBSP research showcase with lots of amazing talks from HDR students and ECRs! Big thank to the ECRA and school for putting on a great event + for the award for my poster on #IO strategies for #DMG #DunLab Hunter Medical Research Institute (HMRI) University of Newcastle Matt Dun, PhD

Thanks Jeff Holst for the shout out! Was great to meet you and share our work with everyone at Cancer & Immunology Ideas Forum from the DunLab on our #DIPG and #DMG IO developments Matt Dun, PhD.

What a team #DunLab 2023-2024

The Seattle Children's's spinout company plans to develop #CARTcell therapies for kids with incurable spinal cord tumors and #braintumors such as #DIPG.

Proud to highlight the recent publication of our #DunLab project (Matt Dun, PhD) in Journal of Clinical Investigation identifying PI3K as a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma (DIPG/DMG). Thread... (1/11) jci.org/articles/view/…

#DunLab / #CSRG / Hunter Medical Research Institute (HMRI) Precision Medicine Research Program has a full time research assistant position open to work on optimising treatments for childhood cancers #pHGG #DIPG #DMG #ALL #pAML newcastle.edu.au/campus-life/ne… Biomed & animal experi helps newcastle.edu.au/profile/matt-d…

Amazing night at the 2024 Little Legs Foundation Gala as part of Alegra's Army. Thank you so much for having us as your guests and your ongoing support to vital #DIPG #DMG research in the #DunLab at University of Newcastle #LLF 🌼

TEAM SHOUT OUT: Hailing from Sweden, Mika Persson was the first recipient of the RUN DIPG International HDR Scholarship back in 2020.🔬 To this day, Mika continues her work within Professor Matt Dun, PhD's team at #DunLab contributing to the goal of #MovingTowardsACure!

Super #ANZCHOG2024asm so far. Privileged to see the pioneering work of Prof Eric Bouffet The Hospital for Sick Children (SickKids) & A/Prof Nick Vitanza (support by RUNDIPG) & delighted that our talented #DunLab PhD students Bryce Thomas & Mika Persson were selected to present their #DIPG #DMG data.

So proud of #DunLab PhD warrior Mika Persson receiving the best abstract award at the #ANZCHOG2024asm!! RUNDIPG

We are thrilled to have A/Prof Nick Vitanza Nick Vitanza present his team's research on "Advancing intracranial CAR T-cells for children with CNS tumours", hosted by Prof Matt Dun, PhD, this week at University of Newcastle #PrecisionMedicine #BrainCancer